Medplus Health Services Ltd (MEDPLUS) Q1FY26 Concall Summary - Jun-2025 Qtr
Performance Overview
- Medplus reported consolidated revenue of Rs. 15,426 million for Q1 FY26.
- Operating EBITDA reached Rs. 728 million, with a margin of 4.7%.
- Pharmacy operations contributed 99% of total revenue, showing 6.6% YoY growth on a GMB basis and 3.3% YoY growth on a net basis.
- Private label sales constituted 21.5% of total revenue, with pharma at 20.8% and non-pharma at 8.7%.
- The company added 124 new stores during the quarter, reaching a total of 4,813 stores.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.